These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24694075)

  • 1. A new regulatory road-map for Alzheimer's disease drug development.
    Becker RE; Greig NH
    Curr Alzheimer Res; 2014 Mar; 11(3):215-20. PubMed ID: 24694075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug development in Alzheimer's disease: the path to 2025.
    Cummings J; Aisen PS; DuBois B; Frölich L; Jack CR; Jones RW; Morris JC; Raskin J; Dowsett SA; Scheltens P
    Alzheimers Res Ther; 2016 Sep; 8():39. PubMed ID: 27646601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
    Kumar S; Chowdhury S; Kumar S
    BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer's disease: focus on brexpiprazole and pimavanserin.
    Caraci F; Santagati M; Caruso G; Cannavò D; Leggio GM; Salomone S; Drago F
    F1000Res; 2020; 9():. PubMed ID: 32695312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing the success rate for Alzheimer's disease drug discovery and development.
    Becker RE; Greig NH
    Expert Opin Drug Discov; 2012 Apr; 7(4):367-70. PubMed ID: 22439785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease: clinical trials and drug development.
    Mangialasche F; Solomon A; Winblad B; Mecocci P; Kivipelto M
    Lancet Neurol; 2010 Jul; 9(7):702-16. PubMed ID: 20610346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's Disease: Advances in Drug Development.
    Piton M; Hirtz C; Desmetz C; Milhau J; Lajoix AD; Bennys K; Lehmann S; Gabelle A
    J Alzheimers Dis; 2018; 65(1):3-13. PubMed ID: 30040716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot.
    Hampel H; Lista S; Khachaturian ZS
    Alzheimers Dement; 2012 Jul; 8(4):312-36. PubMed ID: 22748938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatment of dementia and mild cognitive impairment due to Alzheimer's disease.
    Popp J; Arlt S
    Curr Opin Psychiatry; 2011 Nov; 24(6):556-61. PubMed ID: 21934621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications.
    Sabbagh JJ; Kinney JW; Cummings JL
    Neurobiol Aging; 2013 Jan; 34(1):169-83. PubMed ID: 22464953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory and Health Technology Assessment Considerations for Disease-Modifying Drugs in Alzheimer's Disease.
    Bouvy JC; Jonsson P; O'Rourke D; Chadha AS; Hedberg N; Makady A; Xoxi E; Wied CG; Schiel A; Long R; Gallacher J
    CNS Drugs; 2018 Dec; 32(12):1085-1090. PubMed ID: 30467744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer's disease in Finland.
    Laitinen ML; Bell JS; Lavikainen P; Lönnroos E; Sulkava R; Hartikainen S
    Int Psychogeriatr; 2011 Dec; 23(10):1623-31. PubMed ID: 21867581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of Alzheimer's disease using Chinese medicinal plants: from disease models to potential clinical applications.
    Su Y; Wang Q; Wang C; Chan K; Sun Y; Kuang H
    J Ethnopharmacol; 2014 Mar; 152(3):403-23. PubMed ID: 24412377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug development status for Alzheimer's disease: present scenario.
    Misra S; Medhi B
    Neurol Sci; 2013 Jun; 34(6):831-9. PubMed ID: 23392897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Antipsychotic Drugs and Mortality in Older Persons with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Zhai Y; Yin S; Zhang D
    J Alzheimers Dis; 2016 Mar; 52(2):631-9. PubMed ID: 27031490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Alzheimer's disease therapeutics.
    Rafii MS
    J Alzheimers Dis; 2014; 42 Suppl 4():S545-9. PubMed ID: 25079804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatment of Alzheimer's dementia: state of the art and current dilemmas.
    Omerovic M; Hampel H; Teipel SJ; Buerger K
    World J Biol Psychiatry; 2008; 9(1):69-75. PubMed ID: 17886162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of preclinical Alzheimer's disease: implications for prevention trials.
    Sperling R; Mormino E; Johnson K
    Neuron; 2014 Nov; 84(3):608-22. PubMed ID: 25442939
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.